Overview


According to FutureWise analysis the market for Anti-Asthma TDM Assay Kits in 2023 is US$ 19.12 billion, and is expected to reach US$ 30.98 billion by 2031 at a CAGR of 6.22% over the forecast period of 2024-2032.

Anti-asthma TDM assay kits are tools designed to monitor the drug intensity in the serum and plasma user for asthma. These kits are ready-to-use liquids that are the perfect alternative for the technologies that are used for therapeutic drug monitoring. Therapeutic drug monitoring measures specific drugs and their breakdown metabolites at timed intervals to maintain a stable concentration of the medication in the blood. Some of the monitored medications tend to have a limited "therapeutic index," which is a ratio between the toxic and effective doses of medication. As soon as a drug enters the body, various processes start eliminating the drug from the body. The time required for the body to reduce the drug concentration to half from its initial level is called the half-life of the drug. It generally takes around five half-lives to eradicate a drug from the body.

Many drugs that require therapeutic monitoring are consumed over an individual's lifetime. They must be maintained at stable concentrations year after year while the individual ages and goes through life events that may change that individual's therapeutic level, including pregnancies, infections, temporary illnesses, surgeries, emotional and physical stresses, and accidents. Over time, individuals may also acquire other chronic conditions that require lifetime medication and may affect the processing of their monitored drugs. These conditions include cardiovascular disease, thyroid disease, liver disease, kidney disease, and HIV.

FutureWise Market Research has published a report that provides an insightful analysis anti-asthma TDM assay kits market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-asthma TDM assay kits market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • F. Hoffmann-La Roche AG
  • Bio-Techne Corporation
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc.
  • Eagle Biosciences Inc.
  • Merck KGaA
  • Elabsciance
  • Creative Diagnostics
  • MyBioSource, Inc.
  • Diagnostic Automation/Cortez Diagnostics, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of asthma attributed to factors such as tobacco and other environmental triggers is expected to drive the demand for anti-asthma TDM assay kits market during the forecast period. This emerging incidence enables the need for accurate assessment and management of asthma cases. As the incidence of this respiratory disease continues to grow, it becomes essential to enhance patient care and optimize treatment outcomes. Moreover, integrating TDM assay kits with telemedicine platforms and electronic health records is a crucial driver in transforming healthcare management. A transformative integration emerges by seamlessly incorporating the capabilities of TDM assays with sophisticated digital health systems. This integration increases the precision and efficiency of patient care by boosting real-time data sharing, comprehensive treatment monitoring, and informed decision-making, further propelling market growth. Furthermore, the consensus agreement on the appropriate patient population for its specific pharmacodynamics targets is expected to pose a significant barrier to the anti-asthma TDM assay kits market. This absence of consensus presents impediments to the widespread adoption of TDM. The diversity in patient characteristics, medical conditions, and treatment processes needs individualized approaches, which complicate standardization. Moreover, the high cost of assay kits may significantly hinder their adoption in the market, especially in developing regions. The financial barrier associated with expensive assay kits poses a significant restraint on healthcare providers and institutions seeking to deliver effective asthma management and limited resources. The cost-effectiveness of implementing TDM assay kits becomes a critical factor in decision-making, potentially diverting resources from other essential healthcare needs.

By Product Type

  • ELISA Assay Kits
  • Immunoassay Kits
  • Others

By Assay Type

  • Anti-asthma
  • Bronchodilator

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Research Centers
  • Academic Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to the surging number of asthma patients, and increasing healthcare expenditures are the major factors driving the demand for anti-asthma TDM assay kits within this geographical area during the forecast period. Moreover, as per the AAFA (Asthma and Allergy Foundation of America), about 25 million individuals in the United States are affected by asthma. Furthermore, according to World Health Organization (WHO), most asthma-related deaths occur in low & lower-middle-income countries. Hence there are better opportunities in such regions for the anti-asthma TDM assay kit market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the anti-asthma TDM assay kits market By Product Type, By Assay Type, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Anti-Asthma TDM Assay Kits Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anti-Asthma TDM Assay Kits Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anti-Asthma TDM Assay Kits Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anti-Asthma TDM Assay Kits Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. ELISA Assay Kits
        2. Immunoassay Kits
        3. Others

  • 8.   Global Anti-Asthma TDM Assay Kits Market, By Assay Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Anti-asthma
        2. Bronchodilator

  • 9.   Global Anti-Asthma TDM Assay Kits Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Research Centers
        4. Academic Institutes

  • 10.   North America Anti-Asthma TDM Assay Kits Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.   Latin America Anti-Asthma TDM Assay Kits Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.   Europe Anti-Asthma TDM Assay Kits Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.   Asia Pacific Anti-Asthma TDM Assay Kits Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.   Middle East and Africa Anti-Asthma TDM Assay Kits Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. F. Hoffmann-La Roche AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bio-Techne Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Svar Life Science AB
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thermo Fisher Scientific Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eagle Biosciences Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Merck KGaA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Elabsciance
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Creative Diagnostics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. MyBioSource, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Diagnostic Automation/Cortez Diagnostics, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Anti Asthma Drugs Market

Read More
Partner

Our Clients